Literature DB >> 7531267

[What is the value of arterial chemotherapy in treatment of colorectal liver metastases].

M Lorenz, A Encke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531267     DOI: 10.1007/bf00191576

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


× No keyword cloud information.
  31 in total

1.  CHRONOMETRIC INFUSOR--AN APPARATUS FOR PROTRACTED AMBULATORY INFUSION THERAPY.

Authors:  E WATKINS
Journal:  N Engl J Med       Date:  1963-10-17       Impact factor: 91.245

2.  Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine.

Authors:  D Hohn; J Melnick; R Stagg; D Altman; M Friedman; R Ignoffo; L Ferrell; B Lewis
Journal:  J Clin Oncol       Date:  1985-01       Impact factor: 44.544

3.  Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver.

Authors:  E Watkins; A M Khazei; K S Nahra
Journal:  Surg Gynecol Obstet       Date:  1970-04

Review 4.  Clinical pharmacokinetics of fluorouracil and folinic acid.

Authors:  A Schalhorn; M Kühl
Journal:  Semin Oncol       Date:  1992-04       Impact factor: 4.929

5.  Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study.

Authors:  M Lorenz; C Hottenrott; R Inglis; M Kirkowa-Reimann
Journal:  Gan To Kagaku Ryoho       Date:  1989-12

6.  [Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumors].

Authors:  M Lorenz; C Hottenrott; A Encke
Journal:  Zentralbl Chir       Date:  1993       Impact factor: 0.942

7.  Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease.

Authors:  W J Hodgson; M Friedland; T Ahmed; A Mittelman; H Berman; S Katz; J Morgan; D Byrne
Journal:  Ann Surg       Date:  1986-04       Impact factor: 12.969

8.  A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.

Authors:  N Kemeny; K Seiter; D Niedzwiecki; D Chapman; E Sigurdson; A Cohen; J Botet; P Oderman; P Murray
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

9.  Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.

Authors:  N Kemeny; J Daly; B Reichman; N Geller; J Botet; P Oderman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

10.  Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.

Authors:  R J Stagg; A P Venook; J L Chase; B J Lewis; R S Warren; M Roh; S J Mulvihill; B J Grobman; A A Rayner; D C Hohn
Journal:  J Natl Cancer Inst       Date:  1991-03-20       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.